Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Solventum Corp.(SOLV)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for SOLV
09/24/2026: SOLV (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Solventum Corp. is a recently independent medical technology and healthcare software company spun off from 3M. It operates through segments focused on medical-surgical consumables, dental solutions, and health information systems, leveraging a legacy of innovation and deep clinical adoption. Its primary growth story revolves around digitizing hospital workflows and expanding specialized medical tech, while its core surgical business provides steady, recurring revenue. Investors should monitor its high debt load, integration progress post-spin, and competitive pressures from specialized software and device peers. The stock may appeal to value-oriented investors seeking exposure to established healthcare brands, provided they are comfortable with the execution risks of a new, standalone entity.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | Growth potential exists in digital health, but it is tempered by the mature, slow-growth nature of core medical supply segments. |
| Momentum investor | Weak fit | The stock is currently building its independent trading profile and lacks long-term price trend confirmation. |
| Value investor | Strong fit | The spin-off status and focus on operational efficiency may present a compelling entry point for value-oriented investors. |
| Dividend investor | Mixed fit | Future dividend potential is uncertain as the company prioritizes debt repayment post-spin-off. |
| Low-risk investor | Mixed fit | The substantial debt load and transition risk create volatility that may not suit the most conservative investors. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | As a newly independent company, the stock may experience significant price fluctuations. |
| Valuation risk | Medium | The market is still establishing an appropriate valuation multiple for the company's specific mix of health tech and med-surg assets. |
| Competition risk (Medical Devices/IT) | High | Strong competition from entrenched incumbents could pressure margins and market share. |
| Business quality | Medium / high | The legacy product portfolio is robust, but performance depends on successful operational independence. |
| Dividend income | Low | Limited immediate history of dividend payments makes it less attractive for income-focused investors today. |
| Execution risk | Medium / high | Successfully separating from 3M systems and processes remains a key operational challenge. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Smooth
The stock has moved along a generally orderly path with only modest fluctuations.
Analysis of Past Performance
Type Stock | Historic Profit 17.94% | Avg. Invested days 46 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating  | Upturn Advisory Performance  3.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 09/24/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 15.08B USD | Price to earnings Ratio 10.8 | 1Y Target Price 93.92 |
Price to earnings Ratio 10.8 | 1Y Target Price 93.92 | ||
Volume (30-day avg) 974.7K shares | Beta 0.69 | 52 Weeks Range 62.38 - 94.16 | Updated Date 09/25/2026 |
52 Weeks Range 62.38 - 94.16 | Updated Date 09/25/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 8.2 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| MedSurg | Wound care dressings, surgical solutions, and patient monitoring equipment. | The largest revenue driver, relying on high-volume sales of essential hospital consumables. |
| Health Information Systems | Revenue cycle management and clinical documentation software for healthcare providers. | A key growth area focusing on high-margin software solutions that improve hospital efficiency. |
| Dental | Orthodontic, restorative, and oral care products. | Provides stable, recurring revenue from dental practices globally. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE 10.8 | Forward PE 13.09 | Enterprise Value 19.93B | Price to Sales(TTM) 1.81 |
Enterprise Value 19.93B | Price to Sales(TTM) 1.81 | ||
Enterprise Value to Revenue 2.4 | Enterprise Value to EBITDA 8.08 | Shares Outstanding 170.22M | Shares Floating 144.09M |
Shares Outstanding 170.22M | Shares Floating 144.09M | ||
Percent Insiders 15.34 | Percent Institutions 75.91 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Solventum Corp.
Exchange NYSE | Headquarters Eagan, MN, United States | ||
IPO Launch date 2024-03-26 | CEO & Director Mr. Bryan C. Hanson | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 20584 | Website https://www.solventum.com |
Full time employees 20584 | Website https://www.solventum.com | ||
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.